Evidence map›Paper›PMID 37533979›Full record

ArticleHeliyon2023

Assessment of the impact of the biological larvicide VectoMax G: Combination of

Djepand-Ngognouak Thierry, Landre Djamouko-Djonkam, Foko Dadji Gisèle, Mayi Marie Paul Audrey, Tchuinkam Timoléon, Zébazé-Togouet Serge Hubert, Wondji Charles Sinclair, Antonio-Nkondjio Christophe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Djepand-Ngognouak ThierryMalaria Research Laboratory, Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), P.O. Box 288, Yaoundé, Cameroon.
Landre Djamouko-DjonkamMalaria Research Laboratory, Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), P.O. Box 288, Yaoundé, Cameroon.
Foko Dadji GisèleLaboratory of Zoology, Higher Teacher Training College, University of Yaoundé I, P.O. Box 47, Yaoundé, Cameroon.
Mayi Marie Paul AudreyVector Borne Diseases Laboratory of the Applied Biology and Ecology Research Unit (VBID-URBEA), Department of Animal Biology, Faculty of Sciences of the University of Dschang, P.O. Box 067, Dschang, Cameroon.
Tchuinkam TimoléonVector Borne Diseases Laboratory of the Applied Biology and Ecology Research Unit (VBID-URBEA), Department of Animal Biology, Faculty of Sciences of the University of Dschang, P.O. Box 067, Dschang, Cameroon.
Zébazé-Togouet Serge HubertFaculty of Science, University of Yaoundé I, P.O. Box 337, Yaoundé, Cameroon.
Wondji Charles SinclairVector Biology, Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK.
Antonio-Nkondjio ChristopheMalaria Research Laboratory, Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), P.O. Box 288, Yaoundé, Cameroon.

Funding

Wellcome Trust 202687/Z/16/Z
6 · The paper itself

Abstract

There has been a renewed interest for larviciding during the recent decade. Although biological larvicides are considered not to be harmful to non-target organisms, there is still not sufficient data on the effect of new long-lasting larvicide formulations such as VectoMax G combining

Indexed as

Aquatic vertebratesMacroinvertebratesVectoMax GYaoundéZooplankton

Identifiers

PMID37533979
PMCPMC10391952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.